Zeljko Mijailovic
Kragujevac, SE, Serbia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
ACE2 and TMPRSS2 genetic polymorphisms as potential predictors of COVID-19 severity and outcome in females.
Journal: Frontiers in medicine
Published: September 09, 2024
Its all about IFN-λ4: Protective role of IFNL4 polymorphism against COVID-19-related pneumonia in females.
Journal: Journal of medical virology
Published: March 11, 2023
IFNL3/4 polymorphisms as a two-edged sword: An association with COVID-19 outcome.
Journal: Journal of medical virology
Published: October 08, 2022
Galectin-3 as an important prognostic marker for COVID-19 severity.
Journal: Scientific reports
Published: July 03, 2022
Galectin-1 as the new player in staging and prognosis of COVID-19.
Journal: Scientific reports
Published: August 20, 2021
IL 33 Correlates With COVID-19 Severity, Radiographic and Clinical Finding.
Journal: Frontiers in medicine
Published: July 29, 2021
Predicting Severity and Intrahospital Mortality in COVID-19: The Place and Role of Oxidative Stress.
Predicting Severity and Intrahospital Mortality in COVID-19: The Place and Role of Oxidative Stress.
Journal: Oxidative medicine and cellular longevity
Published: December 28, 2020
SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets.
Journal: PloS one
Published: October 06, 2020
Micro-elimination of HCV as a possible therapeutic strategy: our experience and a review of literature.
Journal: Journal of infection in developing countries
Published: June 23, 2019
Increased systemic sST2 in patients with end stage renal disease contributes to milder liver damage during HCV infection.
Journal: Journal of infection in developing countries
Published: June 05, 2019
Last Updated: 09/26/2026